Role Description
Company Description
RiboBio, founded in 2004, is a leading biotechnology company specializing in RNA-based products and services, supported by state-of-the-art facilities. Recognized as the top provider of RNA-based solutions in China in the 2017 Frost & Sullivan Report, the company offers a diversified portfolio of high-quality reagents including siRNA, miRNA mimics and inhibitors, LncRNA probes, and smart silencing kits for RNA-related research.
With over 20 years of experience in oligonucleotide synthesis, RiboBio delivers comprehensive “end-to-end” RNA-based services spanning drug discovery, development, and manufacturing. These include full CRO and CDMO capabilities for both GMP oligonucleotide APIs and Drug Product. The company continues to expand its global presence and collaborates closely with research institutions and biopharmaceutical companies worldwide to advance RNA therapeutics and innovative nucleic acid technologies.
Role Description
The Business Development Manager is a full-time, hybrid role based in the Greater Boston area, with flexibility to work from home part of the time. This position is responsible for identifying, developing, and managing new business opportunities for RiboBio’s CRO and CDMO services, with a primary focus on biopharmaceutical, biotechnology, and academic partners.
Key Responsibilities
- Prospect, qualify, and convert leads into new business opportunities across the drug discovery and development continuum.
- Conduct customer meetings, presentations, and technical/commercial discussions to understand client needs and propose tailored CRO/CDMO solutions.
- Lead or support negotiations of commercial terms, contribute to contract finalization, and manage the transition from business development to project execution.
- Build and maintain strong, long-term relationships with key accounts and decision-makers.
- Collaborate closely with internal scientific, operations, and marketing teams to refine value propositions, support proposal development, and ensure seamless handoffs.
- Track opportunities, forecast pipeline, and report progress using CRM tools.
- Support market research, competitive analysis, and strategic planning to identify growth opportunities in the RNA therapeutics and oligonucleotide space.
Qualifications
- Demonstrated business development and sales experience in life sciences, biotechnology, or pharmaceutical services, including lead generation, pipeline management, and closing complex, multi-stakeholder deals.
- Strong relationship-building, stakeholder management, and communication skills, with the ability to engage scientific and commercial decision-makers at biopharma, biotech, and academic organizations.
- Solid understanding of RNA technologies, oligonucleotide therapeutics, and outsourced CRO/CDMO services; ability to translate technical concepts into clear commercial value for customers.
- Proficiency in market research, competitive analysis, and strategic planning to identify growth opportunities and inform territory or segment strategies.
- Comfort with CRM tools (e.g., Salesforce or similar) and standard business productivity software for opportunity tracking, forecasting, and reporting.
- Excellent written and verbal communication skills; ability to prepare and deliver compelling proposals and presentations.
Education & Preferred Qualifications
- Bachelor’s degree in a scientific discipline (e.g., Biology, Biochemistry, Biotechnology, Molecular Biology, Pharmacology, Chemistry, or a related life sciences field) is required.
- Advanced degree (Master’s or PhD) in a relevant scientific field, or an MBA with a scientific background, is strongly preferred.
- Equivalent combination of education and extensive industry experience in oligonucleotide/RNA therapeutics, CDMO/CRO services, or related drug development outsourcing will be considered.
- Additional relevant certifications, coursework, or demonstrated expertise in nucleic acid technologies, drug development processes, or commercial strategy is a plus.
- Ongoing professional development and a strong interest in staying current with advances in RNA therapeutics and oligonucleotide manufacturing are valued.